Showing results (181-190 of 258) with videos related to
Sort By:
Pageof 26
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2009
PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transferSai K Saridey, Li Liu, Joseph E Doherty, et al.Pancreas|July 29, 2003
Pancreatic stellate cell activation by ethanol and acetaldehyde: is it mediated by the mitogen-activated protein kinase signaling pathway?J A McCarroll, P A Phillips, S Park, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 1, 1995
Advance directives: a policy-capturing approachP H Raymark, W K Balzer, M E Doherty, et al.Journal of Visualized Experiments : Jove|November 15, 2012
piggyBac transposon system modification of primary human T cellsSunandan Saha, Yozo Nakazawa, Leslie E Huye, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1992
Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cellsV A Fadok, J S Savill, C Haslett, et al.The American Journal of Cardiology|April 1, 1984
Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophyM L Murphy, P N Thenabadu, N de Soyza, et al.The American Journal of Cardiology|December 1, 1983
Descriptive characteristics of the electrocardiogram from autopsied men free of cardiopulmonary disease--a basis for evaluating criteria for ventricular hypertrophyM L Murphy, P N Thenabadu, L R Blue, et al.Bioresource Technology|March 31, 2022
Effect of air nanobubbles on oxygen transfer, oxygen uptake, and diversity of aerobic microbial consortium in activated sludge reactorsSudheera Yaparatne, Zachary E Doherty, Andre L Magdaleno, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 16, 2012
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trialDonald P Tashkin, Dennis E Doherty, Edward Kerwin, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 16, 2012
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trialsDonald P Tashkin, Dennis E Doherty, Edward Kerwin, et al.Pageof 26